BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19451733)

  • 21. Double staining with brilliant blue G and double peeling for epiretinal membranes.
    Shimada H; Nakashizuka H; Hattori T; Mori R; Mizutani Y; Yuzawa M
    Ophthalmology; 2009 Jul; 116(7):1370-6. PubMed ID: 19427701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficiency of vitrectomy in diabetic macular edema and morphometry of surgically removed of the internal limiting membrane].
    Kalvoda J; Dusková J; Kovarík Z; Kubena A; Kalvodová B
    Cesk Slov Oftalmol; 2010 Apr; 66(2):76-82. PubMed ID: 20925242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
    Figueroa MS; Contreras I; Noval S
    Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema.
    Kolacny D; Parys-Vanginderdeuren R; Van Lommel A; Stalmans P
    Bull Soc Belge Ophtalmol; 2005; (296):15-23. PubMed ID: 16050416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.
    Ando F; Yasui O; Hirose H; Ohba N
    Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):995-9. PubMed ID: 15592868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.
    DeCroos FC; Shuler RK; Stinnett S; Fekrat S
    Am J Ophthalmol; 2009 Apr; 147(4):627-633.e1. PubMed ID: 19193361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of internal limiting membrane peeling with and without indocyanine green in macular hole surgery.
    Kumagai K; Furukawa M; Ogino N; Uemura A; Larson E
    Retina; 2006; 26(6):613-7. PubMed ID: 16829801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane.
    Lanzetta P; Polito A; Del Borrello M; Narayanan R; Shah VA; Frattolillo A; Bandello F
    Am J Ophthalmol; 2006 Nov; 142(5):771-6. PubMed ID: 17056361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.
    Radetzky S; Walter P; Fauser S; Koizumi K; Kirchhof B; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):273-8. PubMed ID: 15042375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling.
    Kumagai K; Furukawa M; Ogino N; Larson E; Uemura A
    Retina; 2007; 27(9):1249-54. PubMed ID: 18046233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomical and visual outcomes of idiopathic macular hole surgery with internal limiting membrane removal using low-concentration indocyanine green.
    Lai MM; Williams GA
    Retina; 2007; 27(4):477-82. PubMed ID: 17420702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing the deposition of triamcinolone in macular hole by use of whole blood in triamcinolone-assisted membrane peeling.
    Lai CC; Chuang LH; Wang NK; Yeung L; Chen YP; Hwang YS; Chen KJ; Wu WC
    Retina; 2007 Sep; 27(7):932-7. PubMed ID: 17891019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new surgical approach for indocyanine green-assisted internal limiting membrane peeling.
    Avci R; Avci B; Kaderli B; Cavusoglu I
    Ophthalmic Surg Lasers Imaging; 2004; 35(4):292-7. PubMed ID: 15305552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
    Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
    Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pars plana vitrectomy for diabetic pseudophakic macular edema].
    Krásnik V; Ferková S; Hlavácková K; Strmen P
    Cesk Slov Oftalmol; 2004 Jul; 60(4):254-60. PubMed ID: 15369261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery.
    Ferencz M; Somfai GM; Farkas A; Kovács I; Lesch B; Récsán Z; Nemes J; Salacz G
    Am J Ophthalmol; 2006 Nov; 142(5):765-70. PubMed ID: 17056360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural changes of the internal limiting membrane removed during indocyanine green assisted peeling versus conventional surgery for idiopathic macular epiretinal membrane.
    Konstantinidis L; Uffer S; Bovey EH
    Retina; 2009 Mar; 29(3):380-6. PubMed ID: 19060777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical observation of vitrectomy for treatment of diffuse nontraditional diabetic macular edema].
    Liu DC; Wu H; Yang HQ
    Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):492-6. PubMed ID: 21914262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green.
    La Heij EC; Dieudonné SC; Mooy CM; Diederen RM; Liem AT; van Suylen RJ; Hendrikse F
    Am J Ophthalmol; 2005 Dec; 140(6):1123-5. PubMed ID: 16376661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.
    Asami T; Terasaki H; Kachi S; Nakamura M; Yamamura K; Nabeshima T; Miyake Y
    Ophthalmology; 2004 Feb; 111(2):231-7. PubMed ID: 15019368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.